References
- D'Agati V, Appel G B. Renal pathology of human immunodeficiency virus infection. Semin Nephrol 1998; 18: 406–421
- Marras D, Bruggeman L A, Gao F, et al. Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat Med 2002; 8: 522–526
- Atta M G, Gallant J E, Rahman M H, et al. Antiretroviral therapy in the treatment of HIV-associated nephropathy. Nephrol Dial Transplant 2006; 21: 2809–2813
- Szczech L A, Gupta S K, Habash R, et al. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 2004; 66: 1145–1152
- Daugas E, Rougier J-P, Hill G. HAART-related nephropathies in HIV-infected patients. Kidney Int 2005; 67: 393–403
- Roling J, Schmid H, Fischereder M, Draenert R, Goebel F D. HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy. Clin Infect Dis 2006; 42: 1488–1495
- Tanji N, Tanji K, Kambham N, Markowitz G S, Bell A, D'Agati V D. Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion. Hum Pathol 2001; 32: 734–740
- Sheehan H L. Renal morphology in preeclampsia. Kidney Int 1980; 18: 241–252
- Nakamoto Y, Imai H, Yasuda T, Wakui H, Miura A B. A spectrum of clinicopathological features of nephropathy associated with POEMS syndrome. Nephrol Dial Transplant 1999; 14: 2370–2386
- Karumanchi S A, Maynard S E, Stillman I E, Epstein F H, Sukhatme V P. Preeclampsia: a renal perspective. Kidney Int 2005; 67: 2101–2113
- Kitamoto Y, Takeya M, Tokunaga H, Tomita K. Glomerular endothelial cells are maintained by vascular endothelial growth factor in the adult kidney. Tohoku J Exp Med 2001; 195: 43–54
- Maharaj A SR, Saint-Geniez M, Maldonado A E, D'Amore P A. Vascular endothelial growth factor localisation in the adult. Am J Pathol 2006; 168: 639–648
- Eremina V, Sood M, Haigh J, et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 2003; 111: 707–716
- Rusnati M, Urbinati C, Musulin B, et al. Activation of endothelial cell mitogen activated protein kinase ERK (1/2) by extracellular HIV-1 Tat protein. Endothelium 2001; 8: 65–74
- Sgadari C, Barillari G, Toschi E, et al. HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma. Nat Med 2002; 8: 225–232